December 30, 2024
TOPLINE: Eosinophilic esophagitis (EoE) is not associated with the development of esophageal cancer in privately insured US adults younger than 65 years. METHODOLOGY: Because chronic inflammation […]
December 27, 2024
TOPLINE: Coffee consumption is associated with the abundance of the gut bacterium Lawsonibacter asaccharolyticus, suggesting that specific foods can affect the intestinal microbiome. METHODOLOGY: The researchers […]
December 26, 2024
TOPLINE: Vedolizumab treatment within 4 weeks of ileocolonic resection outperformed placebo in preventing postoperative endoscopic recurrence of Crohn’s disease in patients with at least one risk […]
December 26, 2024
TOPLINE: Women with metabolic dysfunction–associated steatotic liver disease (MASLD) have a higher risk for cirrhosis, whereas men with MASLD have elevated risks for hepatocellular carcinoma, hepatic […]
December 26, 2024
TOPLINE: Women with metabolic dysfunction–associated steatotic liver disease (MASLD) have a higher risk for cirrhosis, whereas men with MASLD have elevated risks for hepatocellular carcinoma, hepatic […]
December 24, 2024
TOPLINE: Older adults with celiac disease (CeD) face a higher risk of developing frailty within 5 years than those without the condition, a finding that indicates […]
December 24, 2024
The scientific report that offers evidence-based guidance for the next iteration of the Dietary Guidelines for Americans has been submitted to federal agencies, and the document […]
December 19, 2024
International researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically with ulcerative colitis (UC) and Crohn’s disease (CD). Targeted droplet digital polymerase […]
December 18, 2024
Among patients with eosinophilic esophagitis (EoE), both those who are responsive to proton pump inhibitors (PPIs) and those who are unresponsive to PPI treatment share similar […]